Sign up to save your podcasts
Or
Share Pharma raises its bet on biotech
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pharma raises its bet on biotech
In the past month pharmaceutical companies have spent almost $100bn acquiring biotech companies. The FT's Sarah Neville explains why big pharma is raising its bet on the drug pipelines owned by biotechs, and why analysts expect more consolidation in 2019.
Read more from Sarah at FT.com.
Hosted on Acast. See acast.com/privacy for more information.
View all episodes
By Financial Times
4.5
196196 ratings
In the past month pharmaceutical companies have spent almost $100bn acquiring biotech companies. The FT's Sarah Neville explains why big pharma is raising its bet on the drug pipelines owned by biotechs, and why analysts expect more consolidation in 2019.
Read more from Sarah at FT.com.
Hosted on Acast. See acast.com/privacy for more information.
More shows like Behind the Money
View all
Economist Podcasts
4,182 Listeners
Exchanges
981 Listeners
World Business Report
290 Listeners
54 Listeners
Political Fix
149 Listeners
FT Tech Tonic
97 Listeners
Life and Art from FT Weekend
199 Listeners
FT News Briefing
672 Listeners
The Intelligence from The Economist
2,539 Listeners
The World in Brief from The Economist
1,079 Listeners
The Rachman Review
134 Listeners
Working It
38 Listeners
The Markets
76 Listeners
Untold: Toxic Legacy
136 Listeners
Unhedged
163 Listeners
Bloomberg Daybreak: Europe Edition
4 Listeners
The Economics Show
142 Listeners
Swamp Notes
24 Listeners